M&A Deal Summary |
|
|---|---|
| Date | 2018-04-27 |
| Target | Impax Laboratories - Generic Products and Assets |
| Sector | Life Science |
| Buyer(s) | ANI Pharmaceuticals |
| Sellers(s) | Impax Laboratories |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2001 |
| Sector | Life Science |
| Employees | 897 |
| Revenue | 614M USD (2024) |
ANI Pharmaceuticals is a developer, manufacturer, and marketer of top-quality prescription pharmaceuticals. In two facilities with combined manufacturing, packaging, and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder, and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. ANI Pharmaceuticals was founded in 2001 and is based in Baudette, Minnesota.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 15 |
| Sector: Life Science M&A | 9 of 13 |
| Type: Divestiture M&A Deals | 9 of 11 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 9 of 12 |
| Year: 2018 M&A | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-04-27 |
Amneal Pharmaceuticals - Generic Products and Assets
Bridgewater, New Jersey, United States Amneal Pharmaceuticals LLC - Generic Products and Assets consisting of five approved generic ANDAs and one pipeline product, Erythromycin IR tablets. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-08-09 |
WellSpring Pharma Services
Oakville, Ontario, Canada WellSpring Pharma Services is a pharmaceutical contract manufacturing organization that emphasizes quality, precision and constant improvement. WellSpring is backed by an experienced team of highly skilled pharmaceutical professionals, a modern facility with advanced equipment and a commitment to quality, compliance and customer service. WellSpring adheres to strict Current Good Manufacturing Practice standards and has an excellent audit history with the US Food and Drug Administration and Health Canada. Founded in 2001, WellSpring Pharma Services is headquartered in Ontario, Canada and had approximately 120 employees |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1993 |
| Sector | Life Science |
| Employees | 1,290 |
| Revenue | 860M USD (2015) |
Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company that applies formulation and development techniques, as well as drug delivery technology, to the development, manufacture and marketing of bioequivalent pharmaceutical products. Impax operates in two segments. These include global pharmaceuticals and Impax pharmaceuticals. The global division develops, manufactures, and distributes generic products. The Impax division develops proprietary brand pharmaceutical products that the Company believes represent improvements to already-approved pharmaceutical products addressing the treatment of central nervous system disorders. Impax Laboratories, Inc. was formed in 1993 and is based in Hayward, California.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Divestiture M&A Deals | 2 of 2 |
| State: California M&A | 2 of 2 |
| Country: United States M&A | 3 of 3 |
| Year: 2018 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-01-30 |
CorePharma
Middlesex, New Jersey, United States CorePharma LLC is a manufacturer and marketer of more than 14 drugs in the U.S. CorePharma was founded in 1998 and is based in Middlesex, New Jersey. |
Sell | - |
